Table 7.
Top 10 most co-cited articles.
| Rank | Title | Journal | First author | Total number of citations | Year of publication |
|---|---|---|---|---|---|
| 1 | Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy | Gut Microbiota | Tang Ruqi | 64 | 2018 |
| 2 | Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis | Environmental Microbiology | Lv Long-Xian | 46 | 2016 |
| 3 | Primary sclerosing cholangitis is characterized by intestinal dysbiosis independent from IBD | Gut | João Sabino | 43 | 2016 |
| 4 | The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls | Gut | Martin Kummen | 40 | 2017 |
| 5 | Randomized clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study | Aliment Pharmacology & Therapeutics | J. H. Tabibian | 32 | 2013 |
| 6 | Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis. | Clinical Reviews in Allergy & Immunology | Weihua Chen | 31 | 2020 |
| 7 | Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium | Hepatology | Carlo Selmi | 28 | 2003 |
| 8 | Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis | Hepatology | James H. Tabibian | 28 | 2016 |
| 9 | Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist | Cell Metabolism | Sama I. Sayin | 27 | 2013 |
| 10 | Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis | Hepatol Research | Masanori Furukawa | 26 | 2020 |